L&K Biomed Ltd. (KOSDAQ:156100)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,560.00
-40.00 (-0.87%)
At close: Jul 6, 2026
Market Cap106.28B -13.5%
Revenue (ttm)39.53B +10.2%
Net Income-7.36B
EPS-353.18
Shares Out 22.35M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume49,397
Open4,605.00
Previous Close4,600.00
Day's Range4,460.00 - 4,660.00
52-Week Range4,110.00 - 16,400.00
Beta0.64
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About L&K Biomed

L&K Biomed Ltd., a medical company, manufactures and sells spinal implants in South Korea, the United States, Thailand, and internationally. The company offers spinal products comprising BlueEX-T, BluEX-TC, BluEX-A, BlueEX-L, and BluEX-ATP; BluEX-LT, an advanced lateral cage system for spinal lordosis restoration; PathLoc-TM, an expandable TLIF/PLIF lumbar cage system; AccelFix-XL, an expandable lateral lumbar cage system; AccelFix-XTP, an expandable lumbar cage system for anterior-to-psoas approach; and PathLoc-TA, an expandable ALIF anterior ... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2008
Employees 101
Stock Exchange KOSDAQ
Ticker Symbol 156100
Full Company Profile

Financial Performance

Financial Statements